[
  {
    "ts": "2026-02-04T11:42:38+00:00",
    "headline": "Medtronic set to acquire CathWorks for $585m",
    "summary": "The acquisition remains subject to US Federal Trade Commission clearance and other regulatory approvals.",
    "url": "https://www.medicaldevice-network.com/news/medtronic-to-acquire-cathworks-585m/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "dec2483c-4418-3566-9a62-538e8e5360e4",
      "content": {
        "id": "dec2483c-4418-3566-9a62-538e8e5360e4",
        "contentType": "STORY",
        "title": "Medtronic set to acquire CathWorks for $585m",
        "description": "",
        "summary": "The acquisition remains subject to US Federal Trade Commission clearance and other regulatory approvals.",
        "pubDate": "2026-02-04T11:42:38Z",
        "displayTime": "2026-02-04T11:42:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/0e0afb18d17186d74d4cdc4fe71bb2c3",
          "originalWidth": 1440,
          "originalHeight": 811,
          "caption": "The companies anticipate completing this phase by the close of Medtronic’s FY26. Credit: JHVEPhoto / Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJLTMng5iS7fPVSzNLYl0g--~B/aD04MTE7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/0e0afb18d17186d74d4cdc4fe71bb2c3.cf.webp",
              "width": 1440,
              "height": 811,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NnJu0d4vC6dVkruqh7Smsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/0e0afb18d17186d74d4cdc4fe71bb2c3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/medtronic-to-acquire-cathworks-585m/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-set-acquire-cathworks-585m-114238528.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T19:11:38+00:00",
    "headline": "Medtronic Expands Heart And Diabetes Tools As Valuation Nears Analyst Views",
    "summary": "Medtronic (NYSE:MDT) announced an agreement to acquire CathWorks, aiming to add AI-powered coronary artery disease tools to its interventional cardiology portfolio. The company also reported progress in diabetes care, with Medicare coverage and FDA clearance for its MiniMed 780G system paired with Abbott's Instinct sensor. These updates span Medtronic's cardiovascular and diabetes businesses, touching key areas of chronic disease management. Medtronic shares recently closed at $103.18, with...",
    "url": "https://finance.yahoo.com/news/medtronic-expands-heart-diabetes-tools-191138423.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "93d070e4-c17a-386f-8aab-1c4a1d369aa7",
      "content": {
        "id": "93d070e4-c17a-386f-8aab-1c4a1d369aa7",
        "contentType": "STORY",
        "title": "Medtronic Expands Heart And Diabetes Tools As Valuation Nears Analyst Views",
        "description": "",
        "summary": "Medtronic (NYSE:MDT) announced an agreement to acquire CathWorks, aiming to add AI-powered coronary artery disease tools to its interventional cardiology portfolio. The company also reported progress in diabetes care, with Medicare coverage and FDA clearance for its MiniMed 780G system paired with Abbott's Instinct sensor. These updates span Medtronic's cardiovascular and diabetes businesses, touching key areas of chronic disease management. Medtronic shares recently closed at $103.18, with...",
        "pubDate": "2026-02-04T19:11:38Z",
        "displayTime": "2026-02-04T19:11:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/1ed8b489adaf5834aa75bcdf670c33d0",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/40v7qeAI0CAQrCAgPvp99A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1ed8b489adaf5834aa75bcdf670c33d0.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2xaJVJYH3iYftXfb0QYcEA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/1ed8b489adaf5834aa75bcdf670c33d0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-expands-heart-diabetes-tools-191138423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medtronic-expands-heart-diabetes-tools-191138423.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T22:41:17+00:00",
    "headline": "Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors",
    "summary": "Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.",
    "url": "https://www.fool.com/coverage/stock-market-today/2026/02/04/stock-market-today-feb-4-boston-scientific-plunges-after-cautious-2026-guidance-disappoints-investors/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "246bf717-c9c9-3855-ab68-c485da7394a2",
      "content": {
        "id": "246bf717-c9c9-3855-ab68-c485da7394a2",
        "contentType": "STORY",
        "title": "Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors",
        "description": "",
        "summary": "Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.",
        "pubDate": "2026-02-04T22:41:17Z",
        "displayTime": "2026-02-04T22:41:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/55b24b49be90e3d7c3172a1a4663616e",
          "originalWidth": 1401,
          "originalHeight": 1251,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YEtum08LL7EtBgoHvj.1zQ--~B/aD0xMjUxO3c9MTQwMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/55b24b49be90e3d7c3172a1a4663616e.cf.webp",
              "width": 1401,
              "height": 1251,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VRDnCrmgqxSlvBL_mQSelw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/55b24b49be90e3d7c3172a1a4663616e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/coverage/stock-market-today/2026/02/04/stock-market-today-feb-4-boston-scientific-plunges-after-cautious-2026-guidance-disappoints-investors/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-feb-4-224117498.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]